La historia natural de la sensibilización fúngica en el asma

The natural history of fungal sensitization in asthma

Contenido principal del artículo

Luisa Fernanda Manrique, MD., MSc.
Claudia Patricia Zuluaga, MD.

Resumen

El asma severa con sensibilización fúngica forma parte del continuo de enfermedad, que inicia con el asma y finaliza con la aspergilosis broncopulmonar alérgica. Este grupo de entidades comúnmente son subdiagnosticadas y se pueden asociar a daños pulmonares irreversibles como bronquiectasias y fibrosis pulmonar. Recientemente se han descrito nuevos criterios diagnósticos que ayudarán a un manejo más temprano y beneficiarán la investigación clínica.

Palabras clave:

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Biografía del autor/a (VER)

Luisa Fernanda Manrique, MD., MSc., Hospital General de Medellín y CEMDE S.A. Medellín, Colombia.

Internista, Neumóloga, Hospital General de Medellín y CEMDE S.A. Medellín, Colombia.

Claudia Patricia Zuluaga, MD., Hospital Militar de Medellín. Hernán Ocazionez y Cia S.A, Clínica Medellín de Occidente. Medellín, Colombia.

Radióloga, Hospital Militar de Medellín. Hernán Ocazionez y Cia S.A, Clínica Medellín de Occidente. Medellín, Colombia.

Referencias (VER)

Agarwal R. Severe asthma with fungal sensitization. Curr Allergy Asthma Resp. 2011;11:403–13.

Agarwal R, Chakrabarti A, Shah A, Gupta D, et al. Allergic broncopulmonary aspergilosis: review of the literature and proposal of new diagnostic and classification criteria. Clin Exp Allerg. 2013;43:850–73.

Agarwal R, Aggarwal N, Gupta D, Jindal K. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13:936–44.

Patterson K, Strek Mary E. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146 (5):1358-68.

Hogan C, Denning D. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Sem Resp Crit Care Med. 2011;32(6):682- 92.

Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009;135:805-26.

Greenberg P. When to suspect and work up allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Inmunol. 2013;111:1–4.

Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4:141-50.

Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66:679–85.

Agarwal R, Hhan A, Gupta D, Aggarwal A, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One. 2010;12:e15346.

Franquet T, Müller NL, Gimenez A, Gumbe P, de la Torre J, Bagué S. Spectrum of pulmonary aspergillosis: histolo-gic, clinical, and radiologic findings. RadioGraphics. 2001; 21:825–37.

Angus RM, Davies ML, Cowan MD, McSharry C, Thomson NC. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax. 1994;49:586-89.

Patterson R, Greenberg PA, Halwig JM, et al. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roetgenographic. Arch Intern Med. 1986;146(5):916-18.

Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;110: 685-92.

Mahdavinia M, Grammer LC. Management of allergic bronchopulmonary aspergillosis: a review and update. Ther Adv Respir Dis. 2012;6:173-87.

Hamilton Rg, Marcotte GV, Saini SS. Inmunological methods for quatifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy. J Immunol Methods. 2005;303(1-2):81–91.

Agarwal R, Khan A, Aggarwal AN, et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary apergillosis. J Infect Public Health. 2011;4:235-43.

Jat KR, Walia DK, Khairwa A. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2015;4:11.

Citado por